FEN1 and prostate carcinoma: In the present study, both in vivo and in vitro experiments showed that FEN1 inhibited DTX‐induced apoptosis and reversed G1/S phase arrest caused by DTX in prostate cancer, which eventually promoted tumour growth; knocking down FEN1 yielded the opposite results.